Takashi Kimura

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 138 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +4

TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2

Hitoshi Aizawa, Jun Sawada, Takuto Hideyama et al. · Acta Neuropathologica · 2010 · 117 citations

Life Sciences, Neurology, Neuroscience +17

The Incidence of Gestational Hyperthyroidism and Postpartum Thyroiditis in Treated Patients with Graves' Disease

Tetsuya Tagami, Hanae Hagiwara, Takashi Kimura et al. · Thyroid · 2007 · 115 citations

Medicine, Endocrinology, Obstetrics +14

Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis

Yoshio Bandô, Yoshiaki Hagiwara, Yasuhiro Suzuki et al. · Glia · 2017 · 47 citations

Life Sciences, Immunology, Neuroscience +17

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 40 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15